CG Oncology, Inc. (CGON)
NASDAQ: CGON · Real-Time Price · USD
29.72
+7.35 (32.86%)
Apr 28, 2025, 12:08 PM EDT - Market open

CG Oncology Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
2,2652,183---
Enterprise Value
1,4851,643---
Last Close Price
22.3728.68---
PS Ratio
1955.271916.94---
PB Ratio
2.322.98---
P/TBV Ratio
3.042.98---
EV/Sales Ratio
1304.041442.48---
Debt / Equity Ratio
000.000.130.38
Asset Turnover
0.000.000.000.00-
Quick Ratio
34.7634.7613.179.328.97
Current Ratio
35.3035.3013.629.549.78
Return on Equity (ROE)
-19.18%-19.18%-31.36%-42.85%-
Return on Assets (ROA)
-15.02%-15.02%-19.97%-21.34%-
Return on Capital (ROIC)
-15.60%-15.60%-21.24%-22.42%-
Earnings Yield
-3.95%-4.03%---
FCF Yield
-3.54%-3.62%---
Buyback Yield / Dilution
-1466.47%-1343.03%-15.77%-2.48%-
Updated Mar 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q